Business
Posting of Annual Report and Notice of AGM
ECO Animal Health Group PLC announced the posting of its Annual Report and Accounts for the year ended 31 March 2025, along with the Notice of Annual General Meeting (AGM) and Form of Proxy, to shareholders who elected to receive hard copies. The Annual Report, Notice of AGM, and Form of Proxy are also available on the company's website. The AGM will be held on Thursday 25 September 2025 at 09.00am at The Grange, 100 High Street, London, N14 6BN. Disclaimer*
About this update from Eco Animal Health Group Plc
[{"type":"text","content":"\n\n28 August 2025\n\n\nECO Animal Health Group plc\n(\"ECO\" or the \"Company\")\n \nPosting of Annual Report and Notice of AGM\n\nECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that its Annual Report and Accounts for the year ended 31 March 2025 (\"Annual Report\"), Notice of Annual General Meeting (\"AGM\") and Form of Proxy have today been posted to shareholders who have elected to receive hard copies by post.\nThe Company will hold its AGM at The Grange, 100 High Street, London, N14 6BN on Thursday 25 September 2025 at 09.00am.\nThe Annual Report, Notice of AGM and Form of Proxy will be made available on the Company's website at https://ecoanimalhealth.com/investors/.\n-Ends-\n \nContacts\n\n\n\n\n \nECO Animal Health Group plc\nDavid Hallas (Chief Executive Officer)\nChristopher Wilks (Chief Financial Officer)\n \n\n\n 020 8447 8899\n\n\n\n\nICR Healthcare (Financial PR)\nMary-Jane Elliott\nJessica Hodgson\n \n\n\n020 3709 5700\n \n\n\n\n\nSinger Capital Markets (Nominated Adviser & Joint Broker)\nPhilip Davies\nSam Butcher\n \n\n\n020 7496 3000\n\n\n\n\nInvestec (Joint Broker)\nGary Clarence\nLydia Zychowska\n \n\n\n020 7597 5970\n \n \n \n\n\n\n\nEquity Development\nHannah Crowe\nMatt Evans\n\n\n020 7065 2692\n\n\n\n\n \n\n\n\n\n\n\n\n\n\n\n\n\nAbout ECO Animal Health\nECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.\n \nHeadquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.\n \nOur lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.\n \nClick here for more information: https://ecoanimalhealth.com\n \n\n","length":6569,"tagName":"div"}]